Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 1446363)

Published in Am J Public Health on October 01, 2000

Authors

J E Lawn1, S Reef, B Baffoe-Bonnie, S Adadevoh, E O Caul, G E Griffin

Author Affiliations

1: Department of Child Health, School of Medical Sciences, University of Science and Technology, Kumasi, Ghana, West Africa. fzl8@cdc.gov

Articles cited by this

Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56

Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) (1983) 4.27

Epidemiology of cataract in childhood: a global perspective. J Cataract Refract Surg (1997) 2.86

Childhood blindness. Eye (Lond) (1988) 2.64

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. BMJ (1999) 2.64

Childhood blindness and low vision in Uganda. Eye (Lond) (1998) 2.51

Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ (1997) 2.33

Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12

A comparison of three tests for rubella antibody screening. J Clin Pathol (1979) 1.71

Rubella immunisation-learning from developed countries. Lancet (1996) 1.64

Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella. Bull World Health Organ (1997) 1.56

Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol (1999) 1.49

Epidemiological studies of rubella virus in a tropical African community. Bull World Health Organ (1980) 1.39

The concept of herd immunity and the design of community-based immunization programmes. Vaccine (1992) 1.31

Congenital rubella in south India: diagnosis using saliva from infants with cataract. BMJ (1996) 1.14

Laboratory diagnosis of rubella: past, present and future. Epidemiol Infect (1991) 1.13

Methods of assessing the impact of congenital rubella infection. Rev Infect Dis (1985) 1.10

Rubella vaccines: past, present and future. Epidemiol Infect (1991) 1.07

The importance of prenatal factors in childhood blindness in India. Dev Med Child Neurol (1997) 1.06

Salivary diagnosis of rubella: a study of notified cases in the United Kingdom, 1991-4. Epidemiol Infect (1998) 1.05

Rubella--world impact. Rev Infect Dis (1985) 1.04

Seroprevalences of Toxoplasma, malaria, rubella, cytomegalovirus, HIV and treponemal infections among pregnant women in Cotonou, Republic of Benin. Acta Trop (1995) 1.03

Congenital heart disease in Nigeria. Clinical and necropsy study of 260 cases. Arch Dis Child (1974) 1.03

Neonatal manifestation of congenital rubella following an outbreak in Trinidad. J Trop Pediatr (1986) 1.02

Otoacoustic emissions as a screening test for hearing impairment in children. Arch Dis Child (1995) 0.89

Congenital rubella in the United Kingdom before 1970: the prevaccine era. Rev Infect Dis (1985) 0.89

Causes of deafness in schools for the deaf in Madras. Int J Pediatr Otorhinolaryngol (1989) 0.89

Prevalence of rubella antibodies on the African continent. Rev Infect Dis (1989) 0.88

Rubella--could do better. Lancet (1998) 0.86

Rubella in Panama: still a problem. Pediatr Infect Dis J (1989) 0.85

Frequency of rubella antibodies in the population of some tropical African countries. Rev Infect Dis (1985) 0.85

Serologic studies in 11,460 pregnant women during the 1972 rubella epidemic in Israel. Am J Epidemiol (1976) 0.85

Simultaneous rubella and measles epidemics in an African community. Cent Afr J Med (1979) 0.84

Profound childhood deafness in Nigeria: a three year survey. Ear Hear (1987) 0.84

Using survey data to assess neonatal tetanus mortality levels and trends in developing countries. Demography (1993) 0.82

The eradication of rubella. JAMA (1999) 0.81

Congenital rubella syndrome at Mombasa. East Afr Med J (1973) 0.81

Distribution of rubella antibodies in Nigeria. Trans R Soc Trop Med Hyg (1977) 0.80

Congenital rubella in Israel following the 1978-79 rubella epidemic. Isr J Med Sci (1983) 0.80

A rubella outbreak in the region of Rijeka, Croatia. Int J Epidemiol (1995) 0.80

Rubella eradication: the countdown begins. West Indian Med J (1998) 0.77

Articles by these authors

(truncated to the top 100)

Sequence and genome organization of a human small round-structured (Norwalk-like) virus. Science (1993) 4.76

Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1998) 4.19

Evaluation of three Chlamydia trachomatis immunoassays with an unbiased, noninvasive clinical sample. J Clin Microbiol (1990) 3.84

Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol (2000) 3.68

Fluorescent antibody studies in chlamydial infections. J Clin Microbiol (1975) 3.46

Non-invasive sampling method for detecting Chlamydia trachomatis. Lancet (1988) 3.45

Enzyme amplified immunoassay: a novel technique applied to direct detection of Chlamydia trachomatis in clinical specimens. J Clin Pathol (1985) 3.33

Postal urine specimens: are they a feasible method for genital chlamydial infection screening? Br J Gen Pract (1999) 3.02

The electron microscopical and physical characteristics of small round human fecal viruses: an interim scheme for classification. J Med Virol (1982) 2.87

Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64

Monoclonal antibody based ELISA for detecting Chlamydia trachomatis. Lancet (1985) 2.60

Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines. Eur J Immunol (1992) 2.52

Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med (1995) 2.50

Human enteric Caliciviridae: the complete genome sequence and expression of virus-like particles from a genetic group II small round structured virus. J Gen Virol (1995) 2.47

Detection of group B and C rotaviruses by polymerase chain reaction. J Clin Microbiol (1991) 2.36

Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation (2000) 2.27

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess (2007) 2.23

Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort. QJM (2002) 2.10

Chlamydial serology in fertile and infertile women. Lancet (1984) 2.10

Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun (2001) 2.09

Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis (2000) 2.05

A small virus in human faeces. Lancet (1973) 2.00

The detection of respiratory syncytial virus in nasopharyngeal aspirates: assessment, formulation, and evaluation of monoclonal antibodies as a diagnostic reagent. J Med Virol (1986) 1.93

A large outbreak of Q fever in the West Midlands: windborne spread into a metropolitan area? Commun Dis Public Health (1998) 1.92

A simplified method for the detection of rubella-specific IgM employing sucrose density fractionation and 2-mercaptoethanol. J Hyg (Lond) (1974) 1.90

Respiratory syncytial and other viruses associated with respiratory disease in infants. Lancet (1971) 1.86

Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit Care Med (1996) 1.86

Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis (2000) 1.82

Evaluation of a genus reactive monoclonal antibody in rapid identification of Chlamydia trachomatis by direct immunofluorescence. Genitourin Med (1985) 1.76

Human enteric Caliciviridae: a new prevalent small round-structured virus group defined by RNA-dependent RNA polymerase and capsid diversity. J Gen Virol (1994) 1.76

Comparison of simple screening tests for fat malabsorption. Br Med J (Clin Res Ed) (1981) 1.75

Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr (1993) 1.71

Astrovirus-associated gastroenteritis in children. J Clin Pathol (1978) 1.70

Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect (2000) 1.64

Chlamydia trachomatis detection and the menstrual cycle. Lancet (1998) 1.63

Polymerase chain reaction detection of small round-structured viruses from two related hospital outbreaks of gastroenteritis using inosine-containing primers. J Med Virol (1995) 1.61

Human enteric caliciviruses have a unique genome structure and are distinct from the Norwalk-like viruses. Arch Virol (1995) 1.60

Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun (1992) 1.58

A school outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol Infect (2003) 1.57

Plasma Volume, "Available (Thiocyanate) Volume" and Total Circulating Plasma Proteins in Normal Adults. Ann Surg (1945) 1.55

Viral gastroenteritis aboard a cruise ship. Lancet (1989) 1.53

Management of hospital outbreaks of gastro-enteritis due to small roundstructured viruses. J Hosp Infect (2000) 1.52

Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. Thorax (1989) 1.49

An outbreak of food-borne gastroenteritis in two hospitals associated with a Norwalk-like virus. J Hyg (Lond) (1983) 1.49

Cloning of noncultivatable human rotavirus by single primer amplification. J Virol (1992) 1.48

Fatal pneumonia after glandular fever and rubella. Lancet (1989) 1.47

Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J Clin Pathol (1989) 1.47

Bioelectrical impedance analysis in human immunodeficiency virus-infected patients: comparison of single frequency with multifrequency, spectroscopy, and other novel approaches. Nutrition (1998) 1.44

Cytomegalovirus infections after open heart surgery. A prospective study. Lancet (1971) 1.44

Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin Exp Immunol (1993) 1.43

Urticaria and hepatitis C. Br J Dermatol (1997) 1.41

Foodborne gastroenteritis due to Norwalk virus in a Winnipeg hotel. CMAJ (1990) 1.39

Subclinical transplacental parvovirus B19 infection: an increased fetal risk? Lancet (1994) 1.38

Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. J Exp Med (1992) 1.38

An outbreak of gastroenteritis in young children caused by adenoviruses. Lancet (1979) 1.37

Letter: Coronavirus particles in faeces from patients with gastroenteritis. Lancet (1975) 1.31

A community outbreak of food-borne small round-structured virus gastroenteritis caused by a contaminated water supply. Epidemiol Infect (1999) 1.30

Capsid sequence diversity in small round structured viruses from recent UK outbreaks of gastroenteritis. J Med Virol (1997) 1.29

The natural history of the perforated duodenal ulcer treated by suture plication. Ann Surg (1976) 1.27

Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever. J Clin Microbiol (1992) 1.25

Antibodies to Chlamydia trachomatis in cervicovaginal secretions: relation to serum antibodies and current chlamydial infection. Sex Transm Dis (1980) 1.25

The differentiation of Chlamydia species by antigen detection in sputum specimens from patients with community-acquired acute respiratory infections. J Infect (1992) 1.25

Laboratory outbreak of Q fever acquired from sheep. Lancet (1982) 1.23

Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet (1987) 1.22

Capsid diversity in small round-structured viruses: molecular characterization of an antigenically distinct human enteric calicivirus. Virus Res (1995) 1.20

Evaluation of a simplified sucrose gradient method for the detection of rubella-specific IgM in routine diagnostic practice. J Med Virol (1978) 1.20

Resolution of fever in Staphylococcus aureus septicaemia--retrospective analysis by means of Cusum plot. J Infect (1986) 1.18

Jejunal mucosal architecture and fat absorption in male homosexuals infected with human immunodeficiency virus. Q J Med (1988) 1.17

Glucose and lactate kinetics in children with severe malaria. J Clin Endocrinol Metab (2000) 1.17

Acute-phase protein response is impaired in severely malnourished children. Clin Sci (Lond) (1993) 1.17

Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci (Lond) (1991) 1.17

Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection. Clin Exp Immunol (1995) 1.16

Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int (1997) 1.16

Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection. J Virol (2000) 1.15

Role of infected food handler in hotel outbreak of Norwalk-like viral gastroenteritis: implications for control. Lancet (1988) 1.14

Surveillance of small round structured virus (SRSV) infection in England and Wales, 1990-5. Epidemiol Infect (1998) 1.14

Coronavirus propagated from patient with non-bacterial gastroenteritis. Lancet (1975) 1.13

Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans. AIDS (1999) 1.12

The laboratory diagnosis of male Chlamydia trachomatis infections--a time for change? J Infect (1992) 1.12

Electron microscopic reporting of gastrointestinal viruses in the United Kingdom, 1985-1987. J Med Virol (1991) 1.11

Pulmonary tuberculosis in Kumasi, Ghana: presentation, drug resistance, molecular epidemiology and outcome of treatment. West Afr J Med (2001) 1.11

National epidemic of Lordsdale Norovirus in the UK. J Clin Virol (2004) 1.10

The development and evaluation of a mu-capture ELISA detecting Chlamydia-specific IgM. Epidemiol Infect (1988) 1.10

Rapid diagnosis of Chlamydia trachomatis infection in patients attending an ophthalmic casualty department. Br J Ophthalmol (1986) 1.10

Tuberculosis of the skull--a rare condition: case report and review of the literature. Neurosurgery (1990) 1.09

In vitro models of mucosal HIV transmission. Nat Med (2000) 1.09

Resolution of the acute-phase response in West African patients receiving treatment for pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.09

Further studies on human enteric coronaviruses. Arch Virol (1977) 1.08

Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr (1995) 1.08

In vitro HIV1 infection of human cervical tissue. Res Virol (1995) 1.06

The risk of acquiring Q fever on farms: a seroepidemiological study. Occup Environ Med (1995) 1.06

Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin Exp Immunol (2000) 1.05

Seroepidemiology of human group C rotavirus in the UK. J Med Virol (1997) 1.04

Zidovudine after occupational exposure to HIV. BMJ (1991) 1.03

The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit. Eur J Immunol (1991) 1.03

Interleukin-8 and Plasmodium falciparum malaria in Thailand. Trans R Soc Trop Med Hyg (1993) 1.03

A systems level strategy for analyzing the cell death network: implication in exploring the apoptosis/autophagy connection. Cell Death Differ (2010) 1.02

The specific IgM response to Mycoplasma pneumoniae infection: interpretation and application to early diagnosis. Epidemiol Infect (1987) 1.02

Q fever in Plymouth, 1972-88. A review with particular reference to neurological manifestations. Epidemiol Infect (1990) 1.02

Autonomic denervation in jejunal mucosa of homosexual men infected with HIV. AIDS (1991) 1.01